Sisli Etfal Training and Research Hospital
Istanbul, 34371, Turkey (Türkiye)
NCT Number: NCT02788942
Laparoscopic cholecystectomy is gold standard for gallstones. In this study the investigators are investigating the effect of the removing of cholecystectomy material from different ports, to the port site infections.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Istanbul, 34371, Turkey (Türkiye)
Laparoscopic cholecystectomy is gold standard for gallstones. But there is no consensus about which port place is optimal for the removing of the cholecystectomy material from the abdomen. There are different port site infections rates in the literature. The minimal tissue damage of laparoscopic cholecystectomy suggests a lower risk of wound infection, but there are series with an infection range of 8 %. The investigators are investigating is there any difference at the port site infection rates when the cholecystectomy material removed from different ports from the abdomen at the laparoscopic cholecystectomy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The cholecystectomy material will be removed from epigastric port. This will be experimental group. Port site infection rates will be measured
Time frame: 2 days
The cholecystectomy material will be removed from umbilical port at the control group, from the epigastric port at the experimental group. The port site infection rates will be noted.
Sisli Hamidiye Etfal Training and Research Hospital
Other
The Relationship Between the Removing Port of the Laparoscopic Cholecystectomy Material and the Port Site Infections
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02992951
Bacterial Infections, Bacterial Infections and Mycoses
Hull, East Riding of Yorkshire, United Kingdom
View Trial DetailsNCT05684198
Digestive System Diseases, Infections
Gdansk, Pomeranian Voivodeship, Poland
View Trial DetailsNCT02018094
Amputation Wound, Infections
Hull, United Kingdom
View Trial DetailsNCT03284749
Cesarean Section; Infection, Infections
Croydon, United Kingdom
View Trial Details